https://www.marketscreener.com/quote/stock/HELIXMITH-CO-LTD-16561378/news/Helixmith-Announces-Topline-Results-from-Phase-2A-Study-of-Engensis-for-Treatment-of-ALS-Amyotrophi-41713408/?utm_source=telegram&utm_medium=social&utm_campaign=share